CAMP4 Therapeutics CorporationCAMPNASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank85
3Y CAGR+18.0%
5Y CAGR+35.4%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+18.0%/yr
vs +0.2%/yr prior
5Y CAGR
+35.4%/yr
Recent deceleration
Acceleration
+17.8pp
Accelerating
Percentile
P85
Within normal range
vs 5Y Ago
4.5x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 156.10% |
| Q3 2025 | -8.45% |
| Q2 2025 | 28.99% |
| Q1 2025 | -26.09% |
| Q4 2024 | -19.17% |
| Q3 2024 | 28.73% |
| Q2 2024 | -21.89% |
| Q1 2024 | 7.22% |
| Q4 2023 | -77.87% |
| Q3 2023 | -118.52% |
| Q2 2023 | -156.76% |
| Q1 2023 | -111.78% |
| Q4 2022 | 95.00% |
| Q3 2022 | 40.64% |
| Q2 2022 | -82.89% |
| Q1 2022 | 3.89% |
| Q4 2021 | -258.20% |
| Q3 2021 | 328.76% |
| Q2 2021 | -262.18% |
| Q1 2021 | -73.40% |
| Q4 2020 | 34.35% |
| Q3 2020 | 63.64% |
| Q2 2020 | -30.54% |
| Q1 2020 | 241.53% |
| Q4 2019 | -444.44% |
| Q3 2019 | 94.35% |
| Q2 2019 | -202.24% |
| Q1 2019 | -142.67% |
| Q4 2018 | 258.54% |
| Q3 2018 | -92.11% |
| Q2 2018 | 396.91% |
| Q1 2018 | -71.69% |
| Q4 2017 | -12.79% |
| Q3 2017 | 165.79% |
| Q2 2017 | 128.91% |
| Q1 2017 | 312.86% |
| Q4 2016 | -119.94% |
| Q3 2016 | 35.59% |
| Q2 2016 | -22.07% |
| Q1 2016 | 3.65% |